Basis of Presentation (Details Narrative)	6 Months Ended
	Jan. 31, 2017 USD ($)	Jan. 18, 2017
Reverse stock split ratio	0.001
Accumulated deficit	$ 391,000,000
Working capital deficiency	$ 23,600,000
Hema Diagnostic Systems, LLC
Majority interest		51.00%